PROCEPT BioRobotics
San Jose, United States
Medical & Surgical Robotics · Founded 2009 · Public
PROCEPT BioRobotics develops the HYDROS and AquaBeam robotic systems, which deliver Aquablation therapy for benign prostatic hyperplasia (BPH). The procedure uses ultrasound guidance and a waterjet, with computer-assisted treatment planning to tailor tissue removal to each prostate. The company sells its systems and single-use handpieces to urology clinics and hospitals in the United States and, since 2026, internationally, beginning with the UK. Its installed U.S. base reached 718 systems at the end of 2025. The business is publicly listed on Nasdaq as PRCT and is headquartered in San Jose, California. It reported total revenue of around $308 million for 2025, with growth driven by system placements and consumables.
Visit website- Based in
- San Jose, United States
- Founded
- 2009
- Builds
- Medical & Surgical Robotics
- Industries
- Healthcare
- Stage
- Public
- Team
- 800 to 1,000 people
- Funding raised
- $349M
- Open roles
- None listed today